0001213900-26-043190
SEC filingThe Elmet Group Co. is a U.S.-owned vertically integrated manufacturer of precision-engineered critical materials components (tungsten, molybdenum, niobium) and high-power microwave systems for aerospace, defense, industrial, medical, semiconductor, and energy markets. This S-1/A filing supports its IPO of 7.7 million shares at $13.00 midpoint, raising ~$90.6 million primarily for debt repayment and growth capital.
The Elmet Group Co. positions itself as a critical U.S. national security asset through its vertically integrated production of refractory metals (tungsten, molybdenum, niobium) and high-power microwave systems, serving defense programs like Patriot, Javelin, Hellfire missiles, and national labs (Fermi, Los Alamos). With FY2025 revenue of $201.6M (up 5.9% YoY) and Adjusted EBITDA of $23.8M (11.8% margin), growth is driven by 20% YoY increase in Aerospace/Defense revenue to 41.5% of total, despite raw material volatility from PRC export controls that spiked tungsten prices 800% in early 2026. Backlog surged 38% YoY, led by 76% Aerospace/Defense growth, signaling strong demand amid U.S. reshoring and DoD spending ($839B FY2026 appropriations).
The IPO raises ~$90.6M net at $13/share midpoint (7.7M shares, 28% dilution), primarily repaying $19.8M debt (37% of $53.5M total, including $17.3M related-party) to reduce leverage and interest risk (variable rates). Remaining proceeds fund growth capital (49%) and working capital (29%), supporting acquisitions (7 integrated since 2000) and capex ($41.8M invested past 6 years via DoD grants). Post-IPO, insiders retain 47% ownership, with CEO Peter Anania controlling 62% voting power pre-IPO via dual-class structure (Class B at 10,000 votes/share, to be consolidated post-IPO).
Risks are defense-heavy (41% revenue), with government contracts vulnerable to cuts/delays; PRC supply dominance (80% tungsten) causes volatility despite non-PRC sourcing; material weaknesses in controls (segregation of duties, ITGCs) persist. Competitive moat: sole U.S. tungsten/molybdenum producer, $1B asset replacement cost, specialized extrusion presses (one of two in U.S.). Management's acquisition track record (e.g., H.C. Starck ops in 2023) supports growth strategy amid reshoring tailwinds.